APA

Soares P., Sobrinho-Simões M., . (20000106). Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Soares P, Sobrinho-Simões M, . 20000106. Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Soares P., Sobrinho-Simões M., . (20000106). Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Soares P, Sobrinho-Simões M, . Correspondence re: G. Tallini et al., RET/PTC oncogene activation defines a subset of papillary thyroid carcinomas lacking evidence of progression to poorly differentiated or undifferentiated tumor phenotype. Clin. Cancer Res., 4:287-294, 1998. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20000106.